These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26829444)

  • 1. Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes.
    Knebel B; Strassburger K; Szendroedi J; Kotzka J; Scheer M; Nowotny B; Müssig K; Lehr S; Pacini G; Finner H; Klüppelholz B; Giani G; Al-Hasani H; Roden M;
    J Clin Endocrinol Metab; 2016 May; 101(5):2130-40. PubMed ID: 26829444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics of Type 1 and Type 2 Diabetes.
    Arneth B; Arneth R; Shams M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of Insulin-Stimulated Glucose Disposal in Recent-Onset Type 1 and Type 2 Diabetes.
    Simon MC; Möller-Horigome A; Strassburger K; Nowotny B; Knebel B; Müssig K; Herder C; Szendroedi J; Roden MW;
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2295-2304. PubMed ID: 30689904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
    Abu Bakar MH; Sarmidi MR
    Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Muscle Strength Is Associated With Insulin Resistance in Type 2 Diabetes Patients With Osteoarthritis.
    Zaharia OP; Pesta DH; Bobrov P; Kupriyanova Y; Herder C; Karusheva Y; Bódis K; Bönhof GJ; Knitza J; Simon D; Kleyer A; Hwang JH; Müssig K; Ziegler D; Burkart V; Schett G; Roden M; Szendroedi J
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1062-1073. PubMed ID: 33382877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Insulin Clearance Differently Relates to Increased Liver Lipid Content and Worse Glycemic Control in Recent-Onset Type 2 and Type 1 Diabetes.
    Zaharia OP; Antoniou S; Bobrov P; Karusheva Y; Bódis K; Kupriyanova Y; Schrauwen-Hinderling V; Gastaldelli A; Szendroedi J; Wagner R; Burkart V; Roden M;
    Diabetes Care; 2023 Dec; 46(12):2232-2239. PubMed ID: 37874983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.
    Kelsey MM; Bjornstad P; McFann K; Nadeau K
    Pediatr Diabetes; 2016 May; 17(3):184-90. PubMed ID: 25611822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes.
    Reinauer C; Reinehr T; Baechle C; Karges B; Seyfarth J; Foertsch K; Schebek M; Woelfle J; Roden M; Holl RW; Rosenbauer J; Meissner T
    Horm Res Paediatr; 2018; 89(2):73-81. PubMed ID: 29207397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.
    Gar C; Rottenkolber M; Prehn C; Adamski J; Seissler J; Lechner A
    Crit Rev Clin Lab Sci; 2018 Jan; 55(1):21-32. PubMed ID: 29239245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Profile of Individuals with and without Type 2 Diabetes from Sub-Saharan Africa.
    Skinner SC; Nemkov T; Diaw M; Mbaye MN; Diedhiou D; Sow D; Gueye F; Lopez P; Connes P; D'Alessandro A
    J Proteome Res; 2023 Jul; 22(7):2319-2326. PubMed ID: 37264938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study.
    Palmer ND; Stevens RD; Antinozzi PA; Anderson A; Bergman RN; Wagenknecht LE; Newgard CB; Bowden DW
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E463-8. PubMed ID: 25423564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People.
    Dutta T; Kudva YC; Persson XM; Schenck LA; Ford GC; Singh RJ; Carter R; Nair KS
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1023-33. PubMed ID: 26796761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.
    de Mello VD; Paananen J; Lindström J; Lankinen MA; Shi L; Kuusisto J; Pihlajamäki J; Auriola S; Lehtonen M; Rolandsson O; Bergdahl IA; Nordin E; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Landberg R; Eriksson JG; Tuomilehto J; Hanhineva K; Uusitupa M
    Sci Rep; 2017 Apr; 7():46337. PubMed ID: 28397877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes.
    Saatmann N; Schön M; Zaharia OP; Huttasch M; Strassburger K; Trenkamp S; Kupriyanova Y; Schrauwen-Hinderling V; Kahl S; Burkart V; Wagner R; Roden M;
    Liver Int; 2024 Jan; 44(1):27-38. PubMed ID: 37697960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes.
    Brouwers B; Schrauwen-Hinderling VB; Jelenik T; Gemmink A; Havekes B; Bruls Y; Dahlmans D; Roden M; Hesselink MKC; Schrauwen P
    Clin Sci (Lond); 2017 Aug; 131(15):1905-1917. PubMed ID: 28620012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS).
    Menart-Houtermans B; Rütter R; Nowotny B; Rosenbauer J; Koliaki C; Kahl S; Simon MC; Szendroedi J; Schloot NC; Roden M;
    Diabetes Care; 2014 Aug; 37(8):2326-33. PubMed ID: 25061140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease attenuates the plasma metabolome response to insulin.
    Roshanravan B; Zelnick LR; Djucovic D; Gu H; Alvarez JA; Ziegler TR; Gamboa JL; Utzschneider K; Kestenbaum B; Himmelfarb J; Kahn SE; Raftery D; de Boer IH
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.